These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prevalence and risk factors of sialocele formation after partial superficial parotidectomy: A multi-institutional analysis of 357 consecutive patients. Lee YC; Park GC; Lee JW; Eun YG; Kim SW Head Neck; 2016 Apr; 38 Suppl 1():E941-4. PubMed ID: 25994845 [TBL] [Abstract][Full Text] [Related]
23. The significance of the margin in parotid surgery for pleomorphic adenoma. Witt RL Laryngoscope; 2002 Dec; 112(12):2141-54. PubMed ID: 12461331 [TBL] [Abstract][Full Text] [Related]
24. [Development and results of surgical treatment of pleomorphic adenoma of the parotid gland in 245 patients, 1974-1994]. Leverstein H; van der Wal JE; Tiwari RM; van der Waal I; Snow GB Ned Tijdschr Geneeskd; 1996 Sep; 140(36):1812-6. PubMed ID: 8927143 [TBL] [Abstract][Full Text] [Related]
25. Partial superficial parotidectomy as the method of choice for treating pleomorphic adenomas of the parotid gland. Papadogeorgakis N Br J Oral Maxillofac Surg; 2011 Sep; 49(6):447-50. PubMed ID: 20638162 [TBL] [Abstract][Full Text] [Related]
27. [Surgery of pleomorphic adenoma of the parotid gland]. von Glass W; Pesch HJ; Braun R; Krause J HNO; 1989 Oct; 37(10):426-31. PubMed ID: 2553646 [TBL] [Abstract][Full Text] [Related]
28. [The pathologic basis of partial parotidectomy in parotid pleomorphic adenoma treatment]. Wen Y; Chen R; Wang C Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Oct; 21(5):359-60. PubMed ID: 14650988 [TBL] [Abstract][Full Text] [Related]
29. [Injection of incobotulinum toxin A for the prevention of postoperative salivary fistula and sialocele]. Sipkin AM; Misikov VK; Utiashvili NI Stomatologiia (Mosk); 2021; 100(2):55-59. PubMed ID: 33874662 [TBL] [Abstract][Full Text] [Related]
30. Sialocele formation after partial parotidectomy: Dependent on remnant parotid exposure. Roh JL Head Neck; 2023 May; 45(5):1299-1304. PubMed ID: 36939294 [TBL] [Abstract][Full Text] [Related]
31. Treatment of Frey's syndrome with botulinum toxin type B. Cantarella G; Berlusconi A; Mele V; Cogiamanian F; Barbieri S Otolaryngol Head Neck Surg; 2010 Aug; 143(2):214-8. PubMed ID: 20647122 [TBL] [Abstract][Full Text] [Related]
32. Botulinum toxoid in the management of gustatory sweating (Frey's syndrome) after superficial parotidectomy. Birch JF; Varma SK; Narula AA Br J Plast Surg; 1999 Apr; 52(3):230-1. PubMed ID: 10474477 [TBL] [Abstract][Full Text] [Related]
33. [Surgery in benign parotid tumors: individually adapted or standardized radical interventions?]. Rehberg E; Schroeder HG; Kleinsasser O Laryngorhinootologie; 1998 May; 77(5):283-8. PubMed ID: 9644676 [TBL] [Abstract][Full Text] [Related]
35. [Pleomorphic adenoma of the parotid gland, rules for resection]. de Ridder M; Smeele LE; Balm AJ Ned Tijdschr Geneeskd; 2012; 156(19):A4662. PubMed ID: 22571547 [TBL] [Abstract][Full Text] [Related]
37. Treatment of parotid neoplasms. Dykun RJ; Deitel M; Borowy ZJ; Jackson S Can J Surg; 1980 Jan; 23(1):14-9. PubMed ID: 6244883 [TBL] [Abstract][Full Text] [Related]
38. Superficial parotidectomy: technical modifications based on tumour characteristics. Papadogeorgakis N; Skouteris CA; Mylonas AI; Angelopoulos AP J Craniomaxillofac Surg; 2004 Dec; 32(6):350-3. PubMed ID: 15555516 [TBL] [Abstract][Full Text] [Related]
39. The use of botulinum toxin in Frey's Syndrome. Khoo SG; Keogh IJ; Timon C Ir Med J; 2006 May; 99(5):136-7. PubMed ID: 16892916 [TBL] [Abstract][Full Text] [Related]